Robert Burns
Stock Analyst at HC Wainwright & Co.
(2.09)
# 2,977
Out of 5,030 analysts
459
Total ratings
38.82%
Success rate
-5.82%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Robert Burns
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ADCT ADC Therapeutics | Maintains: Buy | $8 → $7 | $4.08 | +71.57% | 22 | Oct 16, 2025 | |
| NRIX Nurix Therapeutics | Maintains: Buy | $34 → $33 | $9.95 | +231.66% | 17 | Oct 14, 2025 | |
| ZYME Zymeworks | Upgrades: Buy | $13 → $26 | $18.45 | +40.92% | 22 | Oct 14, 2025 | |
| KPTI Karyopharm Therapeutics | Upgrades: Buy | $15 | $6.00 | +150.05% | 3 | Oct 13, 2025 | |
| CATX Perspective Therapeutics | Reiterates: Buy | $10 | $4.65 | +115.05% | 5 | Oct 3, 2025 | |
| PRLD Prelude Therapeutics | Reiterates: Buy | $5 | $1.29 | +287.60% | 17 | Sep 23, 2025 | |
| NUVB Nuvation Bio | Reiterates: Buy | $10 | $3.53 | +183.29% | 15 | Sep 19, 2025 | |
| BBOT BridgeBio Oncology Therapeutics | Initiates: Buy | $27 | $11.38 | +137.36% | 1 | Sep 15, 2025 | |
| CGEM Cullinan Therapeutics | Reiterates: Buy | $24 | $8.07 | +197.40% | 2 | Sep 12, 2025 | |
| IMMX Immix Biopharma | Maintains: Buy | $7 → $8 | $2.71 | +195.20% | 9 | Sep 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $23 → $20 | $10.77 | +85.70% | 2 | Sep 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $4.57 | - | 19 | Sep 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $136 | $104.45 | +30.21% | 45 | Sep 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $34 | $2.88 | +1,080.56% | 4 | Aug 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $14 | $6.41 | +118.41% | 22 | Aug 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $41 → $40 | $18.33 | +118.22% | 5 | Aug 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $19 | $12.97 | +46.49% | 25 | Aug 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $42 | $19.86 | +111.48% | 11 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $53 → $46 | $38.90 | +18.25% | 10 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $10 | $3.97 | +152.21% | 14 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $21 | $16.34 | +28.52% | 13 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $18 → $10 | $2.20 | +354.55% | 3 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $4 | $0.99 | +304.04% | 1 | Jul 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $13 | $9.69 | +34.23% | 8 | Jul 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $48 | $21.75 | +120.69% | 5 | Jul 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $12 | $2.38 | +404.20% | 3 | May 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $73 → $72 | $54.67 | +31.70% | 20 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $3 | $2.63 | +14.07% | 14 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $13 | $9.02 | +44.12% | 12 | Apr 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $4 → $2 | $1.71 | +16.96% | 21 | Mar 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $1.44 | +247.22% | 11 | Mar 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $8 | $1.24 | +545.16% | 17 | Mar 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $5 | $1.83 | +173.22% | 18 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $15.42 | - | 13 | Jan 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $500 → $200 | $33.75 | +492.59% | 5 | May 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $1,320 → $240 | $1.59 | +14,994.34% | 2 | Mar 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $150 | $0.70 | +21,482.73% | 6 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $115 → $7 | $1.49 | +369.80% | 7 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $11 | $3.20 | +243.75% | 1 | Dec 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $50,000 → $45,000 | $5.17 | +870,306.19% | 7 | Nov 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $25 | $3.85 | +549.35% | 1 | Jun 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $13 | $1.61 | +707.45% | 1 | Jan 7, 2021 |
ADC Therapeutics
Oct 16, 2025
Maintains: Buy
Price Target: $8 → $7
Current: $4.08
Upside: +71.57%
Nurix Therapeutics
Oct 14, 2025
Maintains: Buy
Price Target: $34 → $33
Current: $9.95
Upside: +231.66%
Zymeworks
Oct 14, 2025
Upgrades: Buy
Price Target: $13 → $26
Current: $18.45
Upside: +40.92%
Karyopharm Therapeutics
Oct 13, 2025
Upgrades: Buy
Price Target: $15
Current: $6.00
Upside: +150.05%
Perspective Therapeutics
Oct 3, 2025
Reiterates: Buy
Price Target: $10
Current: $4.65
Upside: +115.05%
Prelude Therapeutics
Sep 23, 2025
Reiterates: Buy
Price Target: $5
Current: $1.29
Upside: +287.60%
Nuvation Bio
Sep 19, 2025
Reiterates: Buy
Price Target: $10
Current: $3.53
Upside: +183.29%
BridgeBio Oncology Therapeutics
Sep 15, 2025
Initiates: Buy
Price Target: $27
Current: $11.38
Upside: +137.36%
Cullinan Therapeutics
Sep 12, 2025
Reiterates: Buy
Price Target: $24
Current: $8.07
Upside: +197.40%
Immix Biopharma
Sep 12, 2025
Maintains: Buy
Price Target: $7 → $8
Current: $2.71
Upside: +195.20%
Sep 10, 2025
Maintains: Buy
Price Target: $23 → $20
Current: $10.77
Upside: +85.70%
Sep 8, 2025
Reiterates: Neutral
Price Target: n/a
Current: $4.57
Upside: -
Sep 8, 2025
Reiterates: Buy
Price Target: $136
Current: $104.45
Upside: +30.21%
Aug 26, 2025
Reiterates: Buy
Price Target: $34
Current: $2.88
Upside: +1,080.56%
Aug 26, 2025
Maintains: Buy
Price Target: $16 → $14
Current: $6.41
Upside: +118.41%
Aug 22, 2025
Maintains: Buy
Price Target: $41 → $40
Current: $18.33
Upside: +118.22%
Aug 14, 2025
Maintains: Buy
Price Target: $22 → $19
Current: $12.97
Upside: +46.49%
Aug 12, 2025
Maintains: Buy
Price Target: $40 → $42
Current: $19.86
Upside: +111.48%
Aug 12, 2025
Maintains: Buy
Price Target: $53 → $46
Current: $38.90
Upside: +18.25%
Aug 11, 2025
Maintains: Buy
Price Target: $12 → $10
Current: $3.97
Upside: +152.21%
Aug 6, 2025
Maintains: Buy
Price Target: $22 → $21
Current: $16.34
Upside: +28.52%
Aug 6, 2025
Maintains: Buy
Price Target: $18 → $10
Current: $2.20
Upside: +354.55%
Jul 23, 2025
Assumes: Buy
Price Target: $4
Current: $0.99
Upside: +304.04%
Jul 17, 2025
Maintains: Buy
Price Target: $10 → $13
Current: $9.69
Upside: +34.23%
Jul 2, 2025
Maintains: Buy
Price Target: $40 → $48
Current: $21.75
Upside: +120.69%
May 16, 2025
Reiterates: Buy
Price Target: $12
Current: $2.38
Upside: +404.20%
May 14, 2025
Maintains: Buy
Price Target: $73 → $72
Current: $54.67
Upside: +31.70%
Apr 28, 2025
Maintains: Buy
Price Target: $9 → $3
Current: $2.63
Upside: +14.07%
Apr 14, 2025
Reiterates: Buy
Price Target: $13
Current: $9.02
Upside: +44.12%
Mar 25, 2025
Maintains: Neutral
Price Target: $4 → $2
Current: $1.71
Upside: +16.96%
Mar 20, 2025
Reiterates: Buy
Price Target: $5
Current: $1.44
Upside: +247.22%
Mar 19, 2025
Maintains: Buy
Price Target: $9 → $8
Current: $1.24
Upside: +545.16%
Mar 7, 2025
Maintains: Buy
Price Target: $10 → $5
Current: $1.83
Upside: +173.22%
Jan 28, 2025
Reiterates: Neutral
Price Target: n/a
Current: $15.42
Upside: -
May 8, 2024
Maintains: Buy
Price Target: $500 → $200
Current: $33.75
Upside: +492.59%
Mar 21, 2024
Maintains: Buy
Price Target: $1,320 → $240
Current: $1.59
Upside: +14,994.34%
Aug 8, 2023
Reiterates: Buy
Price Target: $150
Current: $0.70
Upside: +21,482.73%
Jan 24, 2023
Downgrades: Neutral
Price Target: $115 → $7
Current: $1.49
Upside: +369.80%
Dec 22, 2021
Maintains: Buy
Price Target: $12 → $11
Current: $3.20
Upside: +243.75%
Nov 24, 2021
Maintains: Buy
Price Target: $50,000 → $45,000
Current: $5.17
Upside: +870,306.19%
Jun 21, 2021
Assumes: Buy
Price Target: $25
Current: $3.85
Upside: +549.35%
Jan 7, 2021
Maintains: Buy
Price Target: $19 → $13
Current: $1.61
Upside: +707.45%